Literature DB >> 7962168

Polypeptide factors regulating osteogenesis and bone marrow repair.

I A Bab1, T A Einhorn.   

Abstract

Osteogenic growth polypeptides regulate bone cell function in vitro and may act in vivo in an autocrine, paracrine, or endocrine manner. Several of these polypeptides are present in the blood in an inactive form. During postablation bone marrow regeneration these factors may be activated, released from the blood clot, and together with locally produced polypeptides mediate the initial intramedullary/systemic osteogenic phase of this process. Then, the same and/or other polypeptides expressed by stromal cells have the potential to promote the second phase of regeneration that consists of osteoclastogenesis, resorption of the transient intramedullary bone, and hemopoiesis. This may be an indirect influence since these polypeptides can regulate the stromal cell expression of some of the hemopoietic factors. Clinically, the osteogenic growth polypeptides that regulate osteogenesis and hemopoiesis have a potential role in osteoporosis therapy, implant bone surgery, and bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962168     DOI: 10.1002/jcb.240550313

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Characterization and in vitro evaluation of bacterial cellulose membranes functionalized with osteogenic growth peptide for bone tissue engineering.

Authors:  Sybele Saska; Raquel Mantuaneli Scarel-Caminaga; Lucas Novaes Teixeira; Leonardo Pereira Franchi; Raquel Alves Dos Santos; Ana Maria Minarelli Gaspar; Paulo Tambasco de Oliveira; Adalberto Luiz Rosa; Catarina Satie Takahashi; Younès Messaddeq; Sidney José Lima Ribeiro; Reinaldo Marchetto
Journal:  J Mater Sci Mater Med       Date:  2012-05-24       Impact factor: 3.896

2.  Distraction osteogenesis enhances remodeling of remote bones of the skeleton: a pilot study.

Authors:  Julia F Funk; Gert Krummrey; Carsten Perka; Michael J Raschke; Hermann J Bail
Journal:  Clin Orthop Relat Res       Date:  2009-05-29       Impact factor: 4.176

3.  Two molecular weight species of thrombospondin-2 are present in bone and differentially modulated in fractured and nonfractured tibiae in a murine model of bone healing.

Authors:  Andrea I Alford; Anita B Reddy; Steven A Goldstein; Prithvi Murthy; Riyad Tayim; Gorav Sharma
Journal:  Calcif Tissue Int       Date:  2012-02-24       Impact factor: 4.333

4.  Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity.

Authors:  J Aguirre; L Buttery; M O'Shaughnessy; F Afzal; I Fernandez de Marticorena; M Hukkanen; P Huang; I MacIntyre; J Polak
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.